Pontifícia Universidade Católica do Paraná
13
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.7%
1 terminated/withdrawn out of 13 trials
87.5%
+1.0% vs industry average
15%
2 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Use of Biocompatible Thermoplastic Impregnated With Vancomycin as a Temporary Orthopedic Spacer
Role: collaborator
Ross Operation Failure Database
Role: collaborator
Cell Therapy Associated With Endobronchial Valve
Role: collaborator
Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy
Role: lead
Gender-Relevant Tobacco Cessation Among Women in Brazil
Role: collaborator
Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes
Role: lead
Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair
Role: collaborator
Safety and Efficacy of Autologous Bone Marrow Stem Cells for Lower Extremity Ischemia Treating
Role: lead
Prebiotic in Chronic Kidney Disease Patients
Role: collaborator
Caffeine as a Therapy for Parkinson's Disease
Role: collaborator
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
Role: collaborator
Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema
Role: collaborator
Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients
Role: lead
All 13 trials loaded